Treasury Yield Surge Challenges RiskFree Status Pushing Investors Toward HigherYielding Bonds Tech Giants Pledge Up to 500 Billion for AI Infrastructure in US SpaceX Successfully Launches Starship on Second Attempt After Previous Scrub Oil Prices Advance as Markets Question Prospects for USIran Diplomatic Breakthrough New York Fed Study Highlights Disproportionate Impact of Rising Gas Prices on LowerIncome Households Chinas New Strategic Blueprint Signals Potential Shift in Global EV and AI Standards CMS Q1 2026 Earnings Slight EPS Beat Amid Steady Utility Operations MLM Q1 2026 Earnings EPS Slightly Misses Estimates Stock Gains on Resilient Demand XOMAP Q1 2026 Earnings EPS Misses Estimates with Significant Negative Surprise Griffon Corporation GFF Q1 2026 Earnings EPS Beats Estimates Stock Gains Ground Cerus Corporation CERS Q1 2026 Earnings Narrowing Losses Beat Estimates as Cost Discipline Strengthens CMSC Q1 2026 Earnings EPS Beats Estimates Modest Stock Uptick Pebblebrook Hotel Trust PEB Holds Steady Near Support Whats Driving the Flat Trading OXLCZ Edges Lower in Quiet Trading as Bond Market Sentiment Remains Cautious China SXT Pharmaceuticals SXTC Sees Uptick Amid Support Holding CBL International Limited BANL Edges Higher on Modest Volume Faces Key Resistance at 043 Levi Strauss LEVI Shares Surge 291 as Denim Giant Gains Momentum USIran Talks Show Progress but Key Disagreements Persist on Uranium Enrichment and Strait of Hormuz Tolls Geosphere Capitals Arvind Sanger Cautiously Optimistic on Indian Markets Eyes Earnings Revival Inside SpaceXs IPO Goldman Sachs and Morgan Stanley Lead Wall Streets Role in Potential RecordBreaking Listing Jim Cramer Highlights Two Stocks with Potential Upside in Morning Meeting Warren Buffetts Tiny Purchase in March May Have Been Revealed in Berkshire Filing AMD Announces Over 10 Billion Investment in Taiwans AI Semiconductor Ecosystem Bloom Energy Surges 12 on 26 Billion Deal with European AI Infrastructure Firm Nebius VIV Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter ADMA Biologics Reverses Lower Support Levels Tested After Recent Rally